LivaNova (LIVN) EBT (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.54% |
| Dec 31, 2025 | -18.51% |
| Sep 30, 2025 | 1.77% |
| Jun 30, 2025 | 110.56% |
| Mar 31, 2025 | -658.86% |
| Dec 31, 2024 | 27.09% |
| Sep 30, 2024 | 105.85% |
| Jun 30, 2024 | 163.13% |
| Mar 31, 2024 | 63.73% |
| Dec 31, 2023 | -4,667.24% |
| Sep 30, 2023 | -137.46% |
| Jun 30, 2023 | -45.95% |
| Mar 31, 2023 | 52.77% |
| Dec 31, 2022 | 106.03% |
| Sep 30, 2022 | -658.42% |
| Jun 30, 2022 | 241.19% |
| Mar 31, 2022 | 342.13% |
| Dec 31, 2021 | 94.47% |
| Sep 30, 2021 | 20.90% |
| Jun 30, 2021 | -87.12% |
| Mar 31, 2021 | 90.69% |
| Dec 31, 2020 | -1,511.83% |
| Sep 30, 2020 | 13.62% |
| Jun 30, 2020 | -260.65% |
| Mar 31, 2020 | 96.07% |
| Dec 31, 2019 | -811.96% |
| Sep 30, 2019 | 160.37% |
| Jun 30, 2019 | -65.67% |
| Mar 31, 2019 | 92.32% |
| Dec 31, 2018 | -3,027.21% |
| Sep 30, 2018 | -147.61% |
| Jun 30, 2018 | -15.01% |
| Mar 31, 2018 | 179.70% |
| Dec 31, 2017 | -73.09% |
| Sep 30, 2017 | -53.48% |
| Jun 30, 2017 | 201.94% |
| Mar 31, 2017 | -6.72% |
| Dec 31, 2016 | 5.13% |
| Sep 30, 2016 | 1.82% |
| Jun 30, 2016 | 153.73% |
| Oct 18, 2015 | -238.14% |
| Jul 24, 2015 | 13.96% |